• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » AngioDynamics details $372M Navilyst buyout details | Wall Street Beat

AngioDynamics details $372M Navilyst buyout details | Wall Street Beat

February 8, 2012 By MassDevice staff

MassDevice.com Wall Street Beat

Financial projections from AngioDynamics (NSDQ:ANGO) about its $372 million deal to acquire Navilyst Medical show that it expects to reap some significant rewards from the merger over the short and long terms.

The deal for the vascular device business spun out by Boston Scientific (NYSE:BSX) in 2008 to Avista Capital Partners is expected to close by the end of May, is forecast to add 8 cents to AngioDynamics’ bottom line during fiscal 2013, according to an SEC filing.

The combined entity will throw off at least $50 million in free cash flow during FY2013, according to the filing, which begins June 1. Although net sales have declined some 4.5% since 2009, to an estimated $149 million last year, the driver of that decline – its fluid management business – is "expected to be stable in FY13 and return to modest growth in FY14, led by increased international penetration,” according to the filing.

And run-rate earnings before interest, depreciation, taxes and amortization are slated to reach $70 million during FY2013, excluding the $3 million impact of the medical device tax and including the $6 million AngioDynamics expects to generate in annual savings from the merger.

AngioDynamics said it expects to post sales of about $360 million for fiscal 2013.

“This is a complete deal that, by merging these competitors which are very alike and very similar, but also have very different and complementary strengths and weaknesses, it’s a way to have a refresh for the entire combined company," CEO Joe DeVivo told MassDevice the day after the deal was struck.

Wall Street, however, seemed unimpressed by the new numbers. ANGO shares were down 2.2% to $12.99 as of about 2 p.m. today, after spiking to $14.80 the day the deal was announced.

 Orasi Medical closes up shop

University of Minnesota software startup Orasi Medical has closed its doors after raising at least $8 million since its 2007 founding. Read more

 Becton, Dickinson reveals medical device tax impact

The medical device tax, a 2.3% top-line levy slated to drop next year, will have a $55 million impact on Becton, Dickinson & Co. (NYSE:BDX) next year, according to CFO David Elkins. Read more

 Abiomed hits 52-week high

Abiomed today posted yet another high-water mark, reaching a 52-week high of $23.67. ABMD shares were trading at $23.28 as of about 2:45 p.m. today, up 2.6%.

 Analysts’ ups and downs

  • Abiomed (NSDQ:ABMD): Jefferies maintains "buy" rating, $25 price target.
  • Cerner (NSDQ:CERN): Credit Suisse raises estimates, price target to $72, maintains "neutral" rating.
  • Sirona (NSDQ:SIRO): Morgan Stanley raises price target to $54, sets "overweight" rating.
  • Steris (NYSE:STE): JMP Securities downgrades to "market perform."
  • St. Jude Medical (NYSE:STJ): Barclays Capital maintains “overweight” rating, $48 price target; Leerink Swann sets “outperform” rating, $49 target.
  • Volcano (NSDQ:VOLC): Goldman Sachs raises estimates, price target to $28 through 2015, maintains "neutral" rating.

 Funding Roundup

  • Ohio Third Frontier doles out $2.5M
  • Foundation Radiology closes $2M offering
  • Apollo Endosurgery touts $47.6M round
  • Pyng Medical lands $220k bridge loan
  • ALung Technologies raises $10M Series B
  • iHear Medical drums up $1.8M Series B round
  • Velomedix closes $10.2M Series B round
  • Angels drop $3M on OrthoCor Medical
  • Cardica prices $15M offering
  • InVivo aims to raise $15M with stock offering
  • NeuroMetrix prices $10 million offering

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Abiomed, ALung Technologies Inc., AngioDynamics, Apollo Endosurgery, becton dickinson, Cerner Corp., dextera, Foundation Radiology Group, iHear Medical, InVivo Therapeutics, Navilyst Medical Inc., Neurometrix, Ohio Third Frontier, Orasi Medical Inc., OrthoCor Medical Inc., Pyng Medical, Sirona, Steris Corp., stjudemedical, Velomedix Inc., Volcano Corp.

In case you missed it

  • 3M Health Care Business president is leaving this year
  • Device developer SeaStar Medical hires chief medical officer
  • AccuPulse raises $10M Series A
  • Exactech announces first U.S. surgeries with its nex-gen laser cage glenoid
  • Baxter expects sales growth momentum through 2025
  • Vivera picks up new patent for electronic dose-controlled drug delivery devices
  • Stryker launches dynamic compression system for foot, ankle applications
  • Entegris opens Life Sciences Technology Center in Massachusetts
  • Glucose monitor maker Know Labs expands leadership team
  • inHeart wins FDA clearance for 3D cardiac modeling software
  • How Glytec is advancing insulin management in the hospital
  • Anumana wins FDA breakthrough nod for AI algorithm that detects pulmonary hypertension
  • FDA clears RapidAI’s pulmonary embolism triage platform
  • Report: Dexcom in talks to acquire Insulet
  • Henry Schein investors push back on executive pay
  • Alcon to pay $60M to acquire Kala Pharmaceuticals’ dry eye treatment
  • Creo Medical inks collaboration agreement with Intuitive

RSS From Medical Design & Outsourcing

  • 3M Health Care Business president is leaving this year
    3M Health Care Business Group President Mojdeh Poul will retire from the company on July 1, 2022. Poul joined Maple Grove, Minnesota-based 3M (NYSE:MMM) in 2011 as the global business VP of critical and chronic care solutions. She later became VP and general manager of the company’s food safety business and president of numerous 3M… […]
  • Iterative Scopes announces positive data in Skout AI colonoscopy algorithm clinical trial
    Iterative Scopes this week announced positive trial data in a study of its colorectal cancer screening algorithm, Skout. Cambridge, Massachusetts-based Iterative Scopes designed Skout as a computer-aided device (CADe) that uses artificial intelligence and computer vision technology to detect suspicious tissue and provide real-time feedback for gastroenterologists performing the procedure. Get the full story on… […]
  • Device developer SeaStar Medical hires chief medical officer
    SeaStar Medical has hired Dr. Kevin Chung as chief medical officer of the medtech developer starting July 1. Denver-based SeaStar is developing a platform therapy focused on hyperinflammation of vital organs. The company’s Selective Cytopheretic Device was designated as a breakthrough device by the FDA earlier this year. SeaStar is set to go public in… […]
  • Varta presents microbattery product portfolio at Computex 2022
    Varta will present its broad product portfolio of microbatteries, which make a wide range of future-proof applications possible, at Computex in Taipei starting today. Varta’s microbattery product portfolio ranges from rechargeable lithium-ion button cells to nickel metal hydride button cells, primary silver oxide cells, primary lithium button cells and cylindrical lithium batteries to hydrogen gas… […]
  • Entegris opens Life Sciences Technology Center in Massachusetts
    Entegris (Nasdaq:ENTG) announced today that it opened a new Life Sciences Technology Center in Billerica, Massachusetts. The new Life Sciences Technology Center was built to offer life sciences customers the opportunity to leverage Entegris’ cold-chain supply expertise to optimize processes, reduce costs and increase speed to market. Get the full story at our sister site,… […]
  • MedAcuity hires SVP of business development
    Medtech software development firm MedAcuity today said it has hired Simon Johnson as SVP of business development. Westford, Massachusetts-based MedAcuity said Johnson previously built the client partner team and managed strategic clients at digital consultancy Mobiquity. He also served as SVP of client services at GreenPages Technologies, responsible for driving services revenue growth leading to… […]
  • Henry Schein investors push back on executive pay
    Nearly half of Henry Schein (Nasdaq:HSIC) shareholders who voted at this month’s annual meeting voted against the company’s pay packages for top executives, according to a new SEC filing. About 48.5% of voting shareholders voted against the company’s executive pay plan in what’s known as the Say-on-Pay vote, according to vote results of the May… […]
  • Creo Medical inks collaboration agreement with Intuitive
    Creo Medical Group (LON: CREO) announced today that it has signed a multi-year collaboration agreement with Intuitive to make certain Creo surgical technologies compatible with the surgical robotic giant’s systems. The London exchange reacted by sending CREO shares up more than 4% to 100 pence apiece by the close of trading today. As of midday… […]
  • MedTrace Pharma moves forward on 15 O-water imaging tech
    MedTrace Pharma announced the first person scanned in its Rapid-Water-Flow Phase 3 clinical trial, further testing its tech to bring 15 O-water to imaging. The first subject scan took place at Aarhus University Hospital in Denmark, using 15 O-water produced, dosed and injected through MedTrace’s P3 automated delivery system. The clinical trial aims to evaluate… […]
  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS